294 related articles for article (PubMed ID: 18283624)
1. Killer dendritic cells and their potential role in immunotherapy.
Ullrich E; Chaput N; Zitvogel L
Horm Metab Res; 2008 Feb; 40(2):75-81. PubMed ID: 18283624
[TBL] [Abstract][Full Text] [Related]
2. Killer dendritic cells: mechanisms of action and therapeutic implications for cancer.
Wesa AK; Storkus WJ
Cell Death Differ; 2008 Jan; 15(1):51-7. PubMed ID: 17948028
[TBL] [Abstract][Full Text] [Related]
3. Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.
Fujii S; Shimizu K; Hemmi H; Steinman RM
Immunol Rev; 2007 Dec; 220():183-98. PubMed ID: 17979847
[TBL] [Abstract][Full Text] [Related]
4. The 'kiss of death' by dendritic cells to cancer cells.
Chan CW; Housseau F
Cell Death Differ; 2008 Jan; 15(1):58-69. PubMed ID: 17948029
[TBL] [Abstract][Full Text] [Related]
5. Bacillus Calmette-Guérin-pulsed dendritic cells stimulate natural killer T cells and gammadeltaT cells.
Naoe M; Ogawa Y; Takeshita K; Morita J; Iwamoto S; Miyazaki A; Yoshida H
Int J Urol; 2007 Jun; 14(6):532-8; discussion 538. PubMed ID: 17593099
[TBL] [Abstract][Full Text] [Related]
6. [NK cell-based immunotherapy: new prospects and involvement of dendritic cells].
Borg C; Taieb J; Terme M; Maruyama K; Flament C; Angevin E; Zitvogel L
Bull Cancer; 2003; 90(8-9):699-705. PubMed ID: 14609759
[TBL] [Abstract][Full Text] [Related]
7. Natural killer dendritic cells are an intermediate of developing dendritic cells.
Chen L; Calomeni E; Wen J; Ozato K; Shen R; Gao JX
J Leukoc Biol; 2007 Jun; 81(6):1422-33. PubMed ID: 17332372
[TBL] [Abstract][Full Text] [Related]
8. Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections.
Terunuma H; Deng X; Dewan Z; Fujimoto S; Yamamoto N
Int Rev Immunol; 2008; 27(3):93-110. PubMed ID: 18437601
[TBL] [Abstract][Full Text] [Related]
9. Killer dendritic cells link innate and adaptive immunity against established osteosarcoma in rats.
Chauvin C; Philippeau JM; Hémont C; Hubert FX; Wittrant Y; Lamoureux F; Trinité B; Heymann D; Rédini F; Josien R
Cancer Res; 2008 Nov; 68(22):9433-40. PubMed ID: 19010918
[TBL] [Abstract][Full Text] [Related]
10. A central role for tissue-resident dendritic cells in innate responses.
Foti M; Granucci F; Ricciardi-Castagnoli P
Trends Immunol; 2004 Dec; 25(12):650-4. PubMed ID: 15530834
[TBL] [Abstract][Full Text] [Related]
11. Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies.
Fujii S
Trends Immunol; 2008 May; 29(5):242-9. PubMed ID: 18372215
[TBL] [Abstract][Full Text] [Related]
12. NK cells at the interface between innate and adaptive immunity.
Moretta A; Marcenaro E; Parolini S; Ferlazzo G; Moretta L
Cell Death Differ; 2008 Feb; 15(2):226-33. PubMed ID: 17541426
[TBL] [Abstract][Full Text] [Related]
13. [New insights into cytotoxic effector cells].
Rey J; Olive D; Sébahoun G; O'Callaghan T; Costello RT
Bull Cancer; 2005 Nov; 92(11):935-43. PubMed ID: 16316827
[TBL] [Abstract][Full Text] [Related]
14. Links between innate and cognate tumor immunity.
Ghiringhelli F; Apetoh L; Housseau F; Kroemer G; Zitvogel L
Curr Opin Immunol; 2007 Apr; 19(2):224-31. PubMed ID: 17303400
[TBL] [Abstract][Full Text] [Related]
15. Effector and regulatory events during natural killer-dendritic cell interactions.
Moretta L; Ferlazzo G; Bottino C; Vitale M; Pende D; Mingari MC; Moretta A
Immunol Rev; 2006 Dec; 214():219-28. PubMed ID: 17100887
[TBL] [Abstract][Full Text] [Related]
16. Decreased expressions of CD1d molecule on liver dendritic cells in subcutaneous tumor bearing mice.
Tatsumi T; Takehara T; Yamaguchi S; Sasakawa A; Yamamoto M; Fujita Y; Miyagi T; Ohkawa K; Hayashi N
J Hepatol; 2008 Nov; 49(5):779-86. PubMed ID: 18760855
[TBL] [Abstract][Full Text] [Related]
17. The dialogue between human natural killer cells and dendritic cells.
Moretta A
Curr Opin Immunol; 2005 Jun; 17(3):306-11. PubMed ID: 15886122
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell-based vaccines suppress metastatic liver tumor via activation of local innate and acquired immunity.
Yamaguchi S; Tatsumi T; Takehara T; Sasakawa A; Hikita H; Kohga K; Uemura A; Sakamori R; Ohkawa K; Hayashi N
Cancer Immunol Immunother; 2008 Dec; 57(12):1861-9. PubMed ID: 18438665
[TBL] [Abstract][Full Text] [Related]
19. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells, the liver, and transplantation.
Sumpter TL; Abe M; Tokita D; Thomson AW
Hepatology; 2007 Dec; 46(6):2021-31. PubMed ID: 18027875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
